Psykey, Inc. (OTCMKTS:CEOS) Short Interest Update

Psykey, Inc. (OTCMKTS:CEOS) was the recipient of a significant increase in short interest in May. As of May 31st, there was short interest totalling 7,300 shares, an increase of 97.3% from the May 15th total of 3,700 shares. Based on an average daily trading volume, of 342,100 shares, the short-interest ratio is currently 0.0 days.

Psykey Stock Performance

Shares of OTCMKTS CEOS remained flat at $0.02 during midday trading on Friday. 69,000 shares of the stock traded hands, compared to its average volume of 478,089. The firm’s 50 day moving average is $0.02 and its 200 day moving average is $0.03. Psykey has a 52-week low of $0.01 and a 52-week high of $0.05.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.